ZHANG, YINQING – Trademark Portfolio

Entity Type: 01

ZHANG, YINQING holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ZIP-EZE and ZIPPIES. The owner is based in TEMPLE CITY, CA.

6129 HART AVENUE

TEMPLE CITY, CA 91780

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NUSCENT
NUSCENT
Abandoned 2015
ZIPPIES
ZIPPIES
Registered 2007
ZIP-EZE
ZIP-EZE
Registered 2007

Trademark Classifications

ZHANG, YINQING's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

16
Paper Goods (2 filings)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does ZHANG, YINQING have?

ZHANG, YINQING has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does ZHANG, YINQING file in?

ZHANG, YINQING files trademarks across 2 Nice Classification classes. The most active classes are Class 16 (Paper Goods), Class 5 (Pharmaceuticals). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.

What are ZHANG, YINQING's most well-known trademarks?

ZHANG, YINQING's registered trademark portfolio includes well-known marks such as ZIP-EZE and ZIPPIES. These are among 2 currently registered trademarks in the portfolio.

What is ZHANG, YINQING's trademark registration success rate?

ZHANG, YINQING has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.